WORLD - UNICEF is scaling up efforts to improve health systems and outcomes for children and families affected by noncommunicable diseases, including sickle cell disease, through partnerships and targeted investments in underserved regions.
UNICEF is working with partners, including Eli Lilly and Company, to strengthen under-resourced health systems and improve access to care for children and families living with noncommunicable diseases (NCDs), such as sickle cell disease.
Understanding Sickle Cell Disease
Sickle cell disease is a group of inherited blood disorders that affect the shape of red blood cells, which can block blood flow and reduce oxygen delivery throughout the body.
The condition affects hundreds of thousands of newborns globally each year and places a significant burden on health systems in low- and middle-income countries.
Without proper diagnosis and treatment, sickle cell disease can lead to severe complications and premature death. However, with early detection and proper care, it can be managed effectively.
Growing Burden of Noncommunicable Diseases
UNICEF highlights that noncommunicable diseases account for a significant share of global mortality and are an increasing concern for children and adolescents.
These conditions can disrupt education, reduce life expectancy, and create substantial economic and social burdens on families.
The organization warns that many health systems in resource-limited settings remain primarily focused on infectious diseases, leaving gaps in long-term care for chronic conditions such as sickle cell disease.
Strengthening Care and Early Detection
Through ongoing initiatives, UNICEF aims to improve access to early diagnosis, treatment, and long-term care by equipping frontline health workers and strengthening primary healthcare systems.
The organization also highlights personal stories, including that of a mother in Nepal living with sickle cell disease, as examples of resilience and the impact of improved access to care supported by UNICEF and its partners.
